Bausch + Lomb is up 12.8%, or $2.18 to $19.16.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BLCO:
- Bausch + Lomb price target raised to $20 from $17 at RBC Capital
- Bausch + Lomb names Brent Saunders as CEO, succeeding Joseph Papa
- FDA approves Bausch Lomb & Modulight’s ML6710i photodynamic laser
- Bausch + Lomb acquires AcuFocus, terms not disclosed
- Bausch + Lomb Novaliq announce GOBI trial met both co-primary endpoints